Drugs
-
First-Time Generic Drug Approvals - December 2012
| Generic Drug Name | Generic Manufacturer | Brand Name | Approval Date | |
|---|---|---|---|---|
| 1 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS, 16 MG/12.5 MG, 32 MG/12.5 MG AND 32 MG/25 MG | MYLAN PHARMACEUTICALS, INC. | ATACAND-HCT TABLETS | 12/4/2012 |
| 2 | AMMONIA N 13 INJECTION USP, 3.75 - 260 mCi/ML at EOS | HOUSTON CYCLOTRON PARTNERS LP | AMMONIA N 13 INJECTION USP, 3.75-35.5 mCi at | 12/14/2012 |
| 3 | LAMOTRIGINE EXTENDED-RELEASE TABLETS, (ONCE A DAY) 25 MG, 50 MG, 100 MG, 200 MG, 250 MG AND 300 MG | ANCHEN PHARMACEUTICALS, INC. | LAMICTAL XR EXTENDED-RELEASE TABLETS | 12/26/2012 |
| 4 | PHENYTOIN CHEWABLE TABLETS USP, 50 MG | MYLAN PHARMACEUTICALS, INC. | DILANTIN CHEWABLE TABLETS | 12/26/2012 |
| 5 | SODIUM FLUORIDE F-18 INJECTION USP, 10-200 mCi/mL AT EOS | HOUSTON CYCLOTRON PARTNERS LP | SODIUM FLUORIDE F-18 INJECTION, USP | 12/26/2012 |
| 6 | TRANEXAMIC ACID TABLETS, 650 MG | WATSON LABORATORIES, INC. - FLORIDA | LYSTEDA TABLETS | 12/27/2012 |
| 7 | METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 27 MG, 36 MG AND 54 MG | MALLINCKRODT INC. | CONCERTA EXTENDED-RELEASE TABLETS | 12/28/2012 |
| 8 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | SANDOZ INC. | MAXALT TABLETS | 12/31/2012 |
| 9 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | MYLAN PHARMACEUTICALS, INC. | MAXALT TABLETS | 12/31/2012 |
| 10 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | NATCO PHARMA LIMITED | MAXALT TABLETS | 12/31/2012 |
| 11 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | AUROBINDO PHARMA LIMITED | MAXALT TABLETS | 12/31/2012 |
| 12 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | GLENMARK GENERICS LIMITED | MAXALT TABLETS | 12/31/2012 |
| 13 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | SUN PHARMA GLOBAL FZE | MAXALT TABLETS | 12/31/2012 |
| 14 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | TEVA PHARNACEUTICALS USA, INC. | MAXALT TABLETS | 12/31/2012 |
| 15 | RIZATRIPTAN BENZOATE TABLETS, 5 MG (BASE) AND 10 MG (BASE) | APOTEX INC. | MAXALT TABLETS | 12/31/2012 |
| 16 | RIZATRIPTAN BENZOATE ORALLY DISINTEGRATING TABLETS, 5 MG (BASE) AND 10 MG (BASE) | MYLAN PHARMACEUTICALS, INC. | MAXALT-MLT ORALLY DISINTEGRATING TABLETS | 12/31/2012 |
-
-







